老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Zentalis Pharmaceuticals, LLC

2.40
-0.1200-4.76%
盘后：2.400.00000.00%16:10 EDT
成交量：57.01万
成交额：138.88万
市值：2.27亿
市盈率：-1.23
高：2.54
开：2.53
低：2.39
收：2.52
52周最高：6.95
52周最低：1.21
股本：9,467.19万
流通股本：7,482.79万
量比：0.70
换手率：0.76%
股息：- -
股息率：- -
每股收益(TTM):-1.9591
每股收益(LYR):-1.9100
净资产收益率：-66.75%
总资产收益率：-33.15%
市净率：1.58
市盈率(LYR):-1.26

数据加载中...

总览公司新闻资讯公告
2020/10/02

重要事件披露

8-K - Current report
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/13

重要事件披露

8-K - Current report
2020/07/31

重要事件披露

8-K - Current report
2020/07/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/27

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/07/02

重要事件披露

8-K - Current report
2020/05/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/15

重要事件披露

8-K - Current report
2020/04/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/31

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/03/13

SEC问询函

CORRESP [Cover] - Correspondence
更多